Lampe; John W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lampe; John W..The latest application filed is for "novel tricyclic compounds as inhibitors of mutant idh enzymes".

Company Profile

4.22.23

Lampe; John W. - Cary NJ
Lampe; John W. - Norfolk MA
LAMPE; John W. - Dedham MA
Lampe; John W. - Apex NC
Lampe; John W. - Rockaway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,508,108 - Fischer , et al. Dec	2019-12-17
Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,442,819 - Fischer , et al. Oc	2019-10-15
Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,086,000 - Fischer , et al. October 2, 2	2018-10-02
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes App 20170369507 - Christian; Fischer ; et al.	2017-12-28
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes App 20170362220 - Fischer; Christian ; et al.	2017-12-21
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes App 20170360800 - Fischer; Christian ; et al.	2017-12-21
Bridged bicyclic RHO kinase inhibitor compounds, compositions and use Grant 8,835,457 - Lampe , et al. September 16, 2	2014-09-16
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,604,218 - Lampe , et al. December 10, 2	2013-12-10
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,604,205 - Lampe , et al. December 10, 2	2013-12-10
Bridged Bicyclic Rho Kinase Inhibitor Compounds, Compositions And Use App 20130281485 - Lampe; John W. ; et al.	2013-10-24
Method For Treating Cardiovascular Diseases Using Rho Kinase Inhibitor Compounds App 20130172324 - LAMPE; John W. ; et al.	2013-07-04
Bridged bicyclic RHO kinase inhibitor compounds, composition and use Grant 8,476,295 - Lampe , et al. July 2, 2	2013-07-02
Method For Treating Diseases Associated With Alterations In Cellular Integrity Using Rho Kinase Inhibitor Compounds App 20130158014 - PETERSON; Ward M. ; et al.	2013-06-20
Bifunctional Rho Kinase Inhibitor Compounds, Composition And Use App 20130131106 - LAMPE; John W. ; et al.	2013-05-23
Method For Treating Ophthalmic Diseases Using Kinase Inhibitor Compounds In Prodrug Forms App 20130131059 - LAMPE; John W. ; et al.	2013-05-23
Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds Grant 8,410,147 - Peterson , et al. April 2, 2	2013-04-02
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition And Use App 20130012543 - LAMPE; John W. ; et al.	2013-01-10
Method For Treating Pulmonary Diseases Using Rho Kinase Inhibitor Compounds App 20130005756 - NAVRATIL; Tomas ; et al.	2013-01-03
Method for treating pulmonary diseases using rho kinase inhibitor compounds Grant 8,299,096 - Navratil , et al. October 30, 2	2012-10-30
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds Grant 8,207,195 - Navratil , et al. June 26, 2	2012-06-26
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition And Use App 20120046275 - Lampe; John W. ; et al.	2012-02-23
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,071,779 - Lampe , et al. December 6, 2	2011-12-06
Cytoskeletal active compounds, composition and use Grant 8,039,465 - Lampe , et al. October 18, 2	2011-10-18
Bridged Bicyclic Rho Kinase Inhibitor Compounds, Composition And Use App 20110144150 - Lampe; John W. ; et al.	2011-06-16
Cytoskeletal Active Compounds, Composition And Use App 20100130572 - LAMPE; John W. ; et al.	2010-05-27
Cytoskeletal active compounds, composition and use Grant 7,666,861 - Lampe , et al. February 23, 2	2010-02-23
Method For Treating Cardiovascular Diseases Using Rho Kinase Inhibitor Compounds App 20100008968 - Lampe; John W. ; et al.	2010-01-14
Method For Treating Pulmonary Diseases Using Rho Kinase Inhibitor Compounds App 20090325958 - Navratil; Tomas ; et al.	2009-12-31
Method For Treating Inflammatory Diseases Using Rho Kinase Inhibitor Compounds App 20090325960 - Fulcher; Emilee H. ; et al.	2009-12-31
Method For Treating Neurological And Neuropathic Diseases Using Rho Kinase Inhibitor Compounds App 20090325934 - Navratil; Tomas ; et al.	2009-12-31
Method For Treating Diseases Associated With Alterations In Cellular Integrity Using Rho Kinase Inhibitor Compounds App 20090325905 - Peterson; Ward M. ; et al.	2009-12-31
Method For Treating Ophthalmic Diseases Using Rho Kinase Inhibitor Compounds App 20090325959 - Vittitow; Jason L. ; et al.	2009-12-31
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition And Use App 20080214614 - Lampe; John W. ; et al.	2008-09-04
Cytoskeletal Active Compounds, Composition And Use App 20080076735 - Lampe; John W. ; et al.	2008-03-27
Cytoskeletal active compounds, compositions and use Grant 7,320,974 - Lampe , et al. January 22, 2	2008-01-22
Cytoskeletal active compounds, compositions and use App 20060217427 - Lampe; John W. ; et al.	2006-09-28
Tricyclic pteridinones and a process for their preparation Grant 6,025,489 - Davey , et al. February 15, 2	2000-02-15
Inhibitors of the conversion of big endothelin to endothelin Grant 5,504,070 - Bihovsky , et al. April 2, 1	1996-04-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.